• Witold Rzyman, Joanna Didkowska, Robert Dziedzic, Tomasz Grodzki, Tadeusz Orłowski, Edyta Szurowska, Renata Langfort, Wojciech Biernat, Dariusz Kowalski, Wojciech Dyszkiewicz, Tadeusz Jędrzejczyk, Tomasz Zdrojewski, Sergiusz Nawrocki, Ewa Jassem, and Mariusz Adamek.
• Department of Thoracic Surgery, Medical University of Gdansk, Sklodowskiej Curie 3a, 80-210 Gdansk, Poland. wrzyman@gumed.edu.pl.
• Adv Respir Med. 2018 Jan 1; 86 (1): 53-74.

IntroductionLung cancer is the most common cancer in Poland and worldwide, and the leading cause of cancer-related deaths. Compared to the present day, the annual number of new cases of lung cancer will have increased by approximately 50%, by 2030. The overall ratio of mortality to incidence totals 0.87 and is among the highest. The five-year survival rate in Poland has recently achieved 13.4%. In 2015, lung cancer screening using low-dose computed tomography (LDCT) was introduced to routine clinical practice in the United States following the publication of the largest randomised study, The National Lung Screening Trial. The implementation of screening programmes in Poland and the rest of Europe also seems unavoidable. Due to the differences, both in the socioeconomic considerations and healthcare funding, compared to that in the United States, the current approach comes down to the awaited results of the European randomised study, NELSON.Material And MethodsDuring the meeting of an expert panel at the "Torakoneptunalia 2016" conference in Jastarnia, Poland, a decision was made to summarise and publish the current data on LDCT lung cancer screening in the form of recommendations, or a position statement. The document was prepared by a team composed of a radiologist, thoracic surgeons, pulmonologists, clinical oncologists, epidemiologists, internists, health prevention specialists and pathologists. It reflects the current body of knowledge about lung cancer, its diagnosis and treatment, and provides recommendations on early detection of lung cancer using LDCT. The recommendations address the screening procedure, the requirements for the teams conducting the screening, and the requirements for radiologists, pathologists and surgeons involved in the diagnosis and treatment of patients.ResultsWhile awaiting the results of the NELSON study and the European position statement on lung cancer screening methodology, the multidisciplinary group of experts presents their position, laying grounds for the development of an action plan for early detection of lung cancer in the upcoming future in Poland.ConclusionsPrimary and secondary prophylaxis are the principal ways to reduce lung cancer mortality. While smoking cessation is a task of utmost importance, it must be accompanied by an effective screening programme if the outcome of the disease is to be improved.

19 keywords...

hide…